News

Published on 14 Oct 2024 on Insider Monkey · via Yahoo Finance

Emergent BioSolutions Inc. (EBS): A Standout Among Best Performing Cheap Stocks...


Article preview image

We recently published a list of 12 Best Performing Cheap Stocks in 2024. In this article, we are going to take a look at where Emergent BioSolutions Inc. (NYSE:EBS) stands against other best performing cheap stocks in 2024.

As we step into the final quarter of 2024, the financial markets continue to navigate a complex terrain shaped by a mix of optimism and uncertainty. The latest jobs report for September came in stronger than expected, signaling resilience in the U.S. labor market and leading many investors to reassess their expectations regarding the Federal Reserve’s monetary policy. This report has led traders to largely eliminate the possibility of a more significant rate cut, now forecasting an 87% chance of a quarter-point reduction in the near future. Despite these concerns, analysts are generally optimistic about the broader market’s prospects as we head towards year-end, thanks to promising earnings growth and stabilizing economic indicators.

NYSE.EBS price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
8 things to know: Under Armour to pay out $434M settlement - Baltimore Business...

Registration has opened for the Baltimore Business Journal's first event of 2025. The event will...

The Business Journals 8 Nov 2024

Emergent BioSolutions Inc (EBS) Q3 2024 Earnings Call Highlights: Strong Revenue...

Emergent BioSolutions Inc (EBS) reports a robust financial performance with a 9% revenue increase...

GuruFocus.com · via Yahoo Finance 8 Nov 2024

Tesla, Alibaba rally; MercadoLibre falls in Thursday's afternoon market cap...

Tesla, Alibaba rally; MercadoLibre falls in Thursday's afternoon market cap stock movers

Investing.com 7 Nov 2024

Emergent BioSolutions (EBS) Q3 2024 Earnings Call Transcript

My name is Chris, and I will be your conference operator today. At this time, I would like to...

The Motley Fool · via AOL 7 Nov 2024

Emergent BioSolutions entering ‘turnaround’ phase, new CEO says - Washington...

Emergent BioSolutions Inc. is heading into its next chapter — or “turnaround” phase, as its CEO...

The Business Journals 7 Nov 2024

Mpox Vaccine Player Emergent BioSolutions Stock Jumps On Upbeat Annual Forecast,...

On Thursday, Emergent BioSolutions Inc. (NYSE:EBS) stock is trading higher on mixed third-quarter...

Benzinga · via Yahoo Finance 7 Nov 2024

Emergent BioSolutions Inc. (EBS): A Standout Among Best Performing Cheap Stocks...

We recently published a list of 12 Best Performing Cheap Stocks in 2024. In this article, we are ...

Insider Monkey · via Yahoo Finance 14 Oct 2024

Emergent BioSolutions Inc (EBS) Q2 2024 Earnings Call Highlights: Navigating...

Total Revenue: $255 million for Q2 2024.NARCAN Sales: $120 million in Q2 2024.Anthrax MCM Sales: ...

GuruFocus.com · via Yahoo Finance 7 Oct 2024

BlackRock Inc. Reduces Stake in Emergent BioSolutions Inc.

Overview of BlackRock's Recent Transaction On August 31, 2024, BlackRock Inc. (Trades, Portfolio)...

GuruFocus.com · via Yahoo Finance 20 Sep 2024

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet -...

Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern reco...

Benzinga 3 May 2024